Clinical Trial Update: Immune Activation Markers in HIV-infected Patients Switching to Long Acting Dual Therapy

View source ↗

Summary

This update reports immune activation marker results from HIV infection patients who switched to a long-acting dual therapy regimen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: Centre Hospitalier de Cannes Simone Veil | Conditions: HIV-1-infection | Status: COMPLETED